Concentrix Corp.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: US20602D1019
USD
36.96
0.56 (1.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.3 M

Shareholding (Feb 2025)

FII

42.47%

Held by 161 FIIs

DII

0

Held by 48 DIIs

Promoter

27.31%

How big is Concentrix Corp.?

22-Jun-2025

As of Jun 18, Concentrix Corp. has a market capitalization of 3,572.36 million, with net sales of 9,588.37 million and net profit of 257.79 million over the latest four quarters.

As of Jun 18, Concentrix Corp. has a market capitalization of 3,572.36 million, categorizing it as a Mid Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 9,588.37 million, while the sum of Net Profit for the same period is 257.79 million.<BR><BR>As of Nov'24, the reporting period shows Shareholder's Funds at 4,039.72 million and Total Assets at 11,991.44 million.

Read More

What does Concentrix Corp. do?

22-Jun-2025

Concentrix Corp. is a mid-cap company in the Miscellaneous industry, with recent net sales of $2.372 billion and a net profit of $67 million. Key metrics include a P/E ratio of 11.00, a dividend yield of 0.60%, and a market cap of $3.572 billion.

Overview:<BR>Concentrix Corp. operates in the Miscellaneous industry and is classified as a mid-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 2,372 Million (Quarterly Results - Feb 2025) <BR>Most recent Net Profit: 67 Million (Quarterly Results - Feb 2025) <BR>Market cap: USD 3,572.36 Million (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 11.00 <BR>Dividend Yield: 0.60% <BR>Debt Equity: 1.16 <BR>Return on Equity: 8.39% <BR>Price to Book: 0.89 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Should I buy, sell or hold Concentrix Corp.?

22-Jun-2025

Is Concentrix Corp. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Concentrix Corp. shows a mildly bullish technical trend despite mixed signals, having underperformed the S&P 500 recently but maintaining a positive year-to-date return.

As of 3 October 2025, the technical trend for Concentrix Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bearish, but the monthly MACD shows a mildly bullish stance. The weekly RSI indicates bullish momentum, while the monthly RSI has no signal. Daily moving averages are mildly bullish, contrasting with the weekly Bollinger Bands, which are bearish, and the monthly Bollinger Bands, which are mildly bearish. The KST is bearish on a weekly basis but mildly bullish monthly. Dow Theory shows no trend in both weekly and monthly assessments.<BR><BR>Concentrix has underperformed the S&P 500 across multiple periods, with a 1-week return of -0.61% compared to the S&P 500's 1.09%, and a 1-month return of -11.67% versus the S&P 500's 4.15%. However, it has a positive year-to-date return of 9.87%, while the S&P 500 has returned 14.18%. Overall, the current technical stance is mildly bullish, but the mixed signals suggest caution.

Read More

Is Concentrix Corp. overvalued or undervalued?

05-Nov-2025

As of October 31, 2025, Concentrix Corp. is considered undervalued with attractive valuation metrics, including a P/E ratio of 11, despite underperforming the S&P 500 with a year-to-date return of -9.87%.

As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a positive shift in its valuation outlook. The company appears undervalued relative to its peers, with a P/E ratio of 11, a Price to Book Value of 0.90, and an EV to EBITDA of 5.71. In comparison, Genpact Ltd. has a P/E of 14.38 and an EV to EBITDA of 10.34, while ADT, Inc. shows a P/E of 10.02 and an EV to EBITDA of 5.12, highlighting Concentrix's more favorable valuation metrics.<BR><BR>Despite its attractive valuation, Concentrix has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -9.87% compared to the S&P 500's 16.30%. This underperformance may suggest that the market has not yet recognized the company's potential, reinforcing the notion that Concentrix is undervalued.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Healthy long term growth as Net Sales has grown by an annual rate of 22.39% and Operating profit at 25.52%

 
2

Flat results in May 25

3

With ROCE of 8.88%, it has a fair valuation with a 0.95 Enterprise value to Capital Employed

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 3,329 Million (Small Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.29%

stock-summary
Debt Equity

1.08

stock-summary
Return on Equity

7.51%

stock-summary
Price to Book

0.78

Revenue and Profits:
Net Sales:
2,417 Million
(Quarterly Results - May 2025)
Net Profit:
40 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-28.88%
0%
-28.88%
6 Months
-32.65%
0%
-32.65%
1 Year
-18.72%
0%
-18.72%
2 Years
-60.9%
0%
-60.9%
3 Years
-69.52%
0%
-69.52%
4 Years
-78.13%
0%
-78.13%
5 Years
-63.67%
0%
-63.67%

Concentrix Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
22.39%
EBIT Growth (5y)
25.52%
EBIT to Interest (avg)
8.89
Debt to EBITDA (avg)
2.54
Net Debt to Equity (avg)
1.08
Sales to Capital Employed (avg)
1.01
Tax Ratio
16.17%
Dividend Payout Ratio
33.39%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
11.33%
ROE (avg)
11.93%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.90
EV to EBIT
10.74
EV to EBITDA
5.71
EV to Capital Employed
0.95
EV to Sales
0.87
PEG Ratio
NA
Dividend Yield
0.59%
ROCE (Latest)
8.88%
ROE (Latest)
8.39%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Feb 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 88 Schemes (39.53%)

Foreign Institutions

Held by 161 Foreign Institutions (42.47%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended May 2025 is 1.54% vs 47.44% in May 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended May 2025 is -37.64% vs -17.03% in May 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "May'25",
        "May'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,417.40",
          "val2": "2,380.70",
          "chgp": "1.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "329.90",
          "val2": "358.70",
          "chgp": "-8.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "75.40",
          "val2": "82.50",
          "chgp": "-8.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-35.80",
          "val2": "-28.60",
          "chgp": "-25.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "40.10",
          "val2": "64.30",
          "chgp": "-37.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "68.10%",
          "val2": "76.30%",
          "chgp": "-0.82%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Nov'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Nov 2024 is 35.20% vs 12.49% in Nov 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Nov 2024 is -21.47% vs -28.25% in Nov 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Nov'24",
        "Nov'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,618.90",
          "val2": "7,114.50",
          "chgp": "35.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,463.90",
          "val2": "1,139.30",
          "chgp": "28.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "321.80",
          "val2": "175.40",
          "chgp": "83.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-117.60",
          "val2": "-154.80",
          "chgp": "24.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "241.70",
          "val2": "307.80",
          "chgp": "-21.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "78.80%",
          "val2": "105.60%",
          "chgp": "-2.68%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - May'25 - YoYstock-summary
May'25
May'24
Change(%)
Net Sales
2,417.40
2,380.70
1.54%
Operating Profit (PBDIT) excl Other Income
329.90
358.70
-8.03%
Interest
75.40
82.50
-8.61%
Exceptional Items
-35.80
-28.60
-25.17%
Consolidate Net Profit
40.10
64.30
-37.64%
Operating Profit Margin (Excl OI)
68.10%
76.30%
-0.82%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended May 2025 is 1.54% vs 47.44% in May 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended May 2025 is -37.64% vs -17.03% in May 2024

Annual Results Snapshot (Consolidated) - Nov'24stock-summary
Nov'24
Nov'23
Change(%)
Net Sales
9,618.90
7,114.50
35.20%
Operating Profit (PBDIT) excl Other Income
1,463.90
1,139.30
28.49%
Interest
321.80
175.40
83.47%
Exceptional Items
-117.60
-154.80
24.03%
Consolidate Net Profit
241.70
307.80
-21.47%
Operating Profit Margin (Excl OI)
78.80%
105.60%
-2.68%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Nov 2024 is 35.20% vs 12.49% in Nov 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Nov 2024 is -21.47% vs -28.25% in Nov 2023

stock-summaryCompany CV
About Concentrix Corp. stock-summary
stock-summary
Concentrix Corp.
Miscellaneous
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available